Argatroban, specific thrombin inhibitor, induced phenotype change of cultured rabbit vascular smooth muscle cells

By Yoshinaga M.   Sunagawa M.   Shimada S.   Nakamura M.   Murayama S.   Kosugi T.  

European Journal of Pharmacology, Vol. 461, Iss. 1, 2003-02 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite

Erratum to ''CP8668, a novel orally active nonsteroidal progesterone receptor modulator with tetrahydrobenzindolone skeleton'' [Eur. J. Pharmacol. 461 (2003) 73-78]

By Tabata Y.   Iizuka Y.   Shinei R.   Kurihara K.-i.   Okonogi T.   Hoshiko S.   Kurata Y.  

European Journal of Pharmacology, Vol. 465, Iss. 3, 2003-04 ,pp. : 299-299

Elsevier

Access to resources Recommend Favorite

Corrigendum to: Effects of antitumor agents on inducible prostacyclin production in vascular smooth muscle [Eur. J. Pharmacol. 376 (1999) 301-305]

By Yasui K.   Suehiro A.   Kakishita E.   Wakabayashi I.  

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 93-93

Elsevier

Access to resources Recommend Favorite

Corrigendum to: Effect of methylene methylimino linkage of antisense oligonucleotide to the platelet-derived growth factor A-chain on growth of vascular smooth muscle cells from spontaneously hypertensive rats [Eur. J. Pharmacol. 392 (2000) 129-132]

By Kishioka H.   Fukuda N.   Nakayama M.   Hu W.-Y.   Satoh C.   Kanmatsuse K.   Bhat B.   Symons A.M.   Manoharan M.  

European Journal of Pharmacology, Vol. 404, Iss. 3, 2000-09 ,pp. : 395-395

Elsevier

Access to resources Recommend Favorite

Erratum to ''Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice'' [Eur. J. Pharmacol. 449 (2002) 293-300]

By Noji T.   Sato H.   Sano J.-i.   Nishikawa S.   Kusaka H.   Karasawa A.  

European Journal of Pharmacology, Vol. 455, Iss. 2, 2002-11 ,pp. : 187-188

Elsevier

Access to resources Recommend Favorite